Literature DB >> 7877422

Predictors of outcome for uvulopalatopharyngoplasty.

K Doghramji1, Z H Jabourian, M Pilla, A Farole, R N Lindholm.   

Abstract

The objective of this study was to assess the value of preoperative fiberoptic nasopharyngoscopy with the Müller maneuver (FNMM) and cephalometric radiography in predicting response to uvulopalatopharyngoplasty (UPPP) in patients with obstructive sleep apnea syndrome. Fifty-three such patients having significant obstruction at the soft palatal level and variable degrees of obstruction at the base-of-tongue level underwent both diagnostic procedures before UPPP. Outcome was assessed by the apnea-plus-hypopnea index (AHI) as determined by polysomnography, which was performed before and after surgery. As a group, patients exhibited a significant 10-point reduction in AHI (46.5 to 36.7). However, 17 (32.1%) were judged to be responders as defined by a reduction of the AHI by an increment of 50% or greater with respect to baseline. Of all the cephalometric variables assessed, soft palate length was the only one that differed between responders and nonresponders (45.5 mm versus 42.6 mm, respectively). However, this difference only approached significance (P = .067). Similarly, FNMM results did not discriminate between responders and nonresponders. These results indicate that preoperative cephalometric radiography and FNMM cannot be reliably used to enhance surgical success.

Entities:  

Mesh:

Year:  1995        PMID: 7877422     DOI: 10.1288/00005537-199503000-00016

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  20 in total

1.  Current diagnostic trends in sleep disordered breathing.

Authors:  Joachim T Maurer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05

Review 2.  Available techniques for objective assessment of upper airway narrowing in snoring and sleep apnea.

Authors:  Christian E Faber; Luisa Grymer
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

3.  [Endoscopy in sleep medicine].

Authors:  J T Maurer; K Hörmann
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

4.  Drug-induced sleep endoscopy changes snoring management plan very significantly compared to standard clinical evaluation.

Authors:  Karen Pilaete; Joris De Medts; Kathelijne Godelieve Delsupehe
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-07       Impact factor: 2.503

5.  Relationships among retropalatal airway, pharyngeal length, and craniofacial structures determined by magnetic resonance imaging in patients with obstructive sleep apnea.

Authors:  Suat Avci; Hatice Lakadamyali; Huseyin Lakadamyali; Erdinc Aydin; Mustafa Agah Tekindal
Journal:  Sleep Breath       Date:  2018-05-05       Impact factor: 2.816

6.  Videoendoscopic Assessment of Uncommon Sites of Upper Airway Obstruction during Sleep.

Authors:  Joachim T. Maurer; Boris A. Stuck; Gerd Hein; Karl Hörmann
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

7.  Associated predictors of therapeutic response to uvulopharyngopalatoplasty for severe obstructive sleep apnea hypopnea syndrome.

Authors:  Su Ru Liu; Hong Liang Yi; Shan Kai Yin; Jian Guan; Bin Chen; Li Li Meng; Kai Ming Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-27       Impact factor: 2.503

8.  Drug-induced sleep endoscopy vs awake Müller's maneuver in the diagnosis of severe upper airway obstruction.

Authors:  Danny Soares; Adam J Folbe; George Yoo; M Safwan Badr; James A Rowley; Ho-Sheng Lin
Journal:  Otolaryngol Head Neck Surg       Date:  2012-09-11       Impact factor: 3.497

9.  Test-retest reliability of drug-induced sleep endoscopy.

Authors:  Krista Rodriguez-Bruno; Andrew N Goldberg; Charles E McCulloch; Eric J Kezirian
Journal:  Otolaryngol Head Neck Surg       Date:  2009-05       Impact factor: 3.497

10.  The predictive value of Muller maneuver in REM-dependent obstructive sleep apnea.

Authors:  Kursat Murat Ozcan; Muge Ozcan; Fatih Ozdogan; Omer Hizli; Huseyin Dere; Adnan Unal
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.